NDC 51662-1326-2 - 2% LIDOCAINE HCI
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51662-1326
- Requested NDC
- 51662-1326-2
- Package NDCs from labels
- 51662-1326-1, 51662-1326-2, 51662-1326-3
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Effective date
- 2024-01-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| 2% LIDOCAINE HCI - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-28 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51662-1326-1 | 2020-02-07 | C162847 | 48780-1 | 9d75b9d0-90f7-f424-e053-dadaa90a57ce | 2% LIDOCAINE HCI INJECTION, USP 1000mg/50mL (20mg/mL) 50mL VIAL |
| 51662-1326-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-90f7-f424-e053-dadaa90a57ce | 2% LIDOCAINE HCI INJECTION, USP 1000mg/50mL (20mg/mL) 50mL VIAL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51662-1326-1 | 2% LIDOCAINE HCI | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 50 | 7 | |
| 51662-1326-2 | 2% LIDOCAINE HCI | 1 mL in 1 POUCH | INJECTION, SOLUTION | 1 | 7 | |
| 51662-1326-3 | 2% LIDOCAINE HCI | 25 in 1 CASE | INJECTION, SOLUTION | 25 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51662-1326 | 2% LIDOCAINE HCI INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 7 | Current NDC, Legacy NDC, 3 package rows | 20240130_78d8fb0a-bfae-6599-e053-2991aa0a2e03.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Cardinal Health 107, LLC | 32513e8b-2a81-436e-8da2-439c1dcbf116 | 2026-09-09 | Warnings, Adverse reactions | 1010033 V13007Z41A |
| Saline | NASAL | Raritan Pharmaceuiticals Inc | 4b178e4e-a10f-4b75-8140-1f7548e203ad | 2026-09-09 | Warnings | 451W47IQ8X |
| Thyroid Support | CALCAREA CARBONICA, CALCAREA IODATA, CAUSTICUM, FERRUM IODATUM, FUCUS VESICULOSUS, KALI IODATUM, NATRUM MURIATICUM, THYROIDINUM (BOVINE) | NaturalCare | 07b4e0ed-2b00-4d0a-ad8f-fc6deff15325 | 2026-09-08 | Warnings | 451W47IQ8X |
| American Safety First Aid | LIDOCAINE HCL | Orazen Inc | ea2f776b-dfd0-6ce4-e053-2995a90af009 | 2026-09-07 | Warnings | V13007Z41A |
| MEDI-FIRST Topical Analgesic | LIDOCAINE HCI | Ultra Distributors Inc | b6f288f7-9ae3-215e-e053-2a95a90aedf6 | 2026-09-07 | Warnings | V13007Z41A |
| MEDI-FIRST | BENZALKONIUM CHLORIDE, LIDOCAINE | Orazen Inc | f508434f-5948-7134-e053-2a95a90a03d7 | 2026-09-05 | Warnings | V13007Z41A |
| MEDI-FIRST | BENZALKONIUM CHLORIDE, LIDOCAINE | Orazen Inc | f522fb0b-3d86-b228-e053-2a95a90a55e9 | 2026-09-05 | Warnings | V13007Z41A |
| Nerve Guard Nerve Relief | LIDOCAINE HYDROCHLORIDE, MENTHOL,MAGNESIUM CHLORIDE | Micelle Laboratories, Incorporated | 6b78f40f-2a7f-4c49-96af-1a95acbf430f | 2026-09-04 | Warnings | V13007Z41A |
| Psoriasis Control | CENTELLA ASIATICA, SODIUM CHLORIDE, AND SILICON DIOXIDE | Forces of Nature | 2db33771-0bb9-49f8-84fa-dddc28e4ba26 | 2026-09-04 | Warnings | 451W47IQ8X |
| Lidocaine Viscous | LIDOCAINE HYDROCHLORIDE | REMEDYREPACK INC. | 6f8d20d2-6a91-4a5b-bfe8-f1baada38442 | 2026-09-03 | Boxed warning, Warnings, Adverse reactions | V13007Z41A |
| KROGER Saline | NASAL | KROGER COMPANY | c84b242b-f46e-4ea8-a3c1-109a47644646 | 2026-09-02 | Warnings | 451W47IQ8X |
| XYLOCAINE MPF | LIDOCAINE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 1986c302-82a0-95a9-e063-6294a90a3339 | 2026-09-02 | Warnings, Adverse reactions | 1737343 |
| HUSTLE BUTTER NUMBING | LIDOCAINE HCL, BENZALKONIUM CHLORIDE | H.B.D. DIST. INC. | 5b4d0390-dac6-4a71-9fdc-5c31543e7c5a | 2026-09-02 | Warnings | V13007Z41A |
| Adrenal Support | ADRENALINUM, ARGENTUM NITRICUM, BERBERIS VULGARIS, NATRUM MURIATICUM, OLEUM MORRHUAE, PETROLEUM, VANADIUM | NaturalCare | 31a5d522-15cd-432a-bf87-f721bcbe2e31 | 2026-09-02 | Warnings | 451W47IQ8X |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | PAI Holdings, LLC dba PAI Pharma | 9920daef-b156-4a14-b641-f714191ffb5c | 2026-09-02 | Warnings, Adverse reactions | V13007Z41A |
| Xtreme Saline Rinse Mix | SODIUM BICARBONATE, SODIUM CHLORIDE | Xtreme Personal Care Inc | 776f417e-e443-4918-8c7a-1913b7dddcd4 | 2026-09-01 | Warnings | 451W47IQ8X |
| Nacl 0.9% Normal Saline Solution | SODIUM CHLORIDE | CHI FUNG TECHNOLOGY COMPANY | 5a53c4c8-c9de-700c-e063-6394a90a3ab5 | 2026-08-31 | Warnings | 451W47IQ8X |
| BMNP Nat Mur | NATRUM MURIATICUM | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5a57ccfd-ab6f-cb2c-e063-6394a90ae9e6 | 2026-08-31 | Warnings | 451W47IQ8X |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | REMEDYREPACK INC. | f824b48c-7039-4ce1-b3df-b3597aba5beb | 2026-08-28 | Warnings, Adverse reactions | V13007Z41A |
| Allergy Care | ADRENALINUM, RAGWEED, POLLEN (AMBROSIA ARTEMISIAEFOLIA), APIS MELLIFICA, ECHINACEA (ANGUSTIFOLIA), HISTAMINUM HYDROCHLORICUM, LEDUM PALUSTRE, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, SULPHUR | NaturalCare | f3ca7f5a-1448-4670-ac02-b47ffb6c5585 | 2026-08-27 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.